Home | Biogen
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
Biogen is a global biotechnology company that specializes in the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases. The company is committed to advancing science and medicine to improve the lives of patients with serious diseases.
1.4M
45000 / day
1.5M
50000 / day
3.8 min
4.2 pages per visit
35%
-
Domain Rating
-
Domain Authority
-
Citation Level
1978
English, etc
Website Key Features
Product Information
Detailed information on Biogen's products, including indications, safety information, and prescribing information.
Research and Development
Insights into Biogen's research initiatives and development pipeline for new therapies.
Patient Support
Resources and support programs for patients and caregivers, including financial assistance and educational materials.
Careers
Information on career opportunities at Biogen, including job listings and company culture.
Investor Relations
Financial information, stock data, and corporate governance details for investors and stakeholders.
News and Media
Latest news releases, media coverage, and company announcements.
Events
Information on upcoming and past events, including conferences, webinars, and community engagements.
Corporate Responsibility
Details on Biogen's commitment to sustainability, diversity, and community involvement.
Global Presence
Information on Biogen's operations and offices around the world.
Contact Us
Contact information for general inquiries, media relations, and investor relations.
Similar Sites and Competitors
Additional information
Headquarters
Cambridge, Massachusetts, United States
Key People
Michel Vounatsos (CEO), Alfred W. Sandrock Jr. (EVP, Research & Development)
Revenue
$13.4 billion (2020)
Number of Employees
Approximately 7,800 (2020)
Stock Symbol
NASDAQ: BIIB
Website
https://www.biogen.com
HTTP headers
Security headers report is a very important part of user data protection. Learn more about http headers for biogen.com